Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Cutting Edge: Role of MASP-3 in the Physiological Activation of Factor D of the Alternative Complement Pathway.

Hayashi M, Machida T, Ishida Y, Ogata Y, Omori T, Takasumi M, Endo Y, Suzuki T, Sekimata M, Homma Y, Ikawa M, Ohira H, Fujita T, Sekine H.

J Immunol. 2019 Sep 15;203(6):1411-1416. doi: 10.4049/jimmunol.1900605. Epub 2019 Aug 9.

PMID:
31399515
2.

Runx1 and RORγt Cooperate to Upregulate IL-22 Expression in Th Cells through Its Distal Enhancer.

Sekimata M, Yoshida D, Araki A, Asao H, Iseki K, Murakami-Sekimata A.

J Immunol. 2019 Jun 1;202(11):3198-3210. doi: 10.4049/jimmunol.1800672. Epub 2019 Apr 26.

PMID:
31028121
3.

CpG methylation prevents YY1-mediated transcriptional activation of the vimentin promoter.

Sekimata M, Murakami-Sekimata A, Homma Y.

Biochem Biophys Res Commun. 2011 Nov 4;414(4):767-72. doi: 10.1016/j.bbrc.2011.09.155. Epub 2011 Oct 7.

PMID:
22005459
4.

CCCTC-binding factor and the transcription factor T-bet orchestrate T helper 1 cell-specific structure and function at the interferon-gamma locus.

Sekimata M, Pérez-Melgosa M, Miller SA, Weinmann AS, Sabo PJ, Sandstrom R, Dorschner MO, Stamatoyannopoulos JA, Wilson CB.

Immunity. 2009 Oct 16;31(4):551-64. doi: 10.1016/j.immuni.2009.08.021. Epub 2009 Oct 8.

5.

Epigenetic control of T-helper-cell differentiation.

Wilson CB, Rowell E, Sekimata M.

Nat Rev Immunol. 2009 Feb;9(2):91-105. doi: 10.1038/nri2487. Review.

PMID:
19151746
6.

Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma.

Schoenborn JR, Dorschner MO, Sekimata M, Santer DM, Shnyreva M, Fitzpatrick DR, Stamatoyannopoulos JA, Wilson CB.

Nat Immunol. 2007 Jul;8(7):732-42. Epub 2007 Jun 3. Erratum in: Nat Immunol. 2007 Aug;8(8):893. Stamatoyonnapoulos, John A [corrected to Stamatoyannopoulos, John A]. Nat Immunol. 2008 Jan;9(1):105.

7.

Negative regulation of CD8 expression via Cd8 enhancer-mediated recruitment of the zinc finger protein MAZR.

Bilic I, Koesters C, Unger B, Sekimata M, Hertweck A, Maschek R, Wilson CB, Ellmeier W.

Nat Immunol. 2006 Apr;7(4):392-400. Epub 2006 Feb 19.

8.

Involvement of poly(ADP-ribose) polymerase 1 in ERBB2 expression in rheumatoid synovial cells.

Kitamura T, Sekimata M, Kikuchi S, Homma Y.

Am J Physiol Cell Physiol. 2005 Jul;289(1):C82-8. Epub 2005 Mar 2.

9.

Regulation of Rb gene expression by an MBD2-interacting zinc finger protein MIZF during myogenic differentiation.

Sekimata M, Homma Y.

Biochem Biophys Res Commun. 2004 Dec 17;325(3):653-9.

PMID:
15541338
10.

Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF.

Sekimata M, Homma Y.

Nucleic Acids Res. 2004 Jan 29;32(2):590-7. Print 2004.

11.

A PLCdelta1-binding protein, p122/RhoGAP, is localized in caveolin-enriched membrane domains and regulates caveolin internalization.

Yamaga M, Sekimata M, Fujii M, Kawai K, Kamata H, Hirata H, Homma Y, Yagisawa H.

Genes Cells. 2004 Jan;9(1):25-37.

12.

An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model.

Sugino T, Kusakabe T, Hoshi N, Yamaguchi T, Kawaguchi T, Goodison S, Sekimata M, Homma Y, Suzuki T.

Am J Pathol. 2002 Jun;160(6):1973-80.

13.

Enhanced activity of variant phospholipase C-delta1 protein (R257H) detected in patients with coronary artery spasm.

Nakano T, Osanai T, Tomita H, Sekimata M, Homma Y, Okumura K.

Circulation. 2002 Apr 30;105(17):2024-9.

PMID:
11980680
14.

Involvement of a novel zinc finger protein, MIZF, in transcriptional repression by interacting with a methyl-CpG-binding protein, MBD2.

Sekimata M, Takahashi A, Murakami-Sekimata A, Homma Y.

J Biol Chem. 2001 Nov 16;276(46):42632-8. Epub 2001 Sep 11.

15.

Wavelength-specific activation of MAP kinase family proteins by monochromatic UV irradiation.

Kabuyama Y, Homma MK, Sekimata M, Homma Y.

Photochem Photobiol. 2001 Feb;73(2):147-52.

PMID:
11272728
16.

Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia.

Nakazato K, Ishibashi T, Nagata K, Seino Y, Wada Y, Sakamoto T, Matsuoka R, Teramoto T, Sekimata M, Homma Y, Maruyama Y.

Atherosclerosis. 2001 Apr;155(2):439-44.

PMID:
11254915
17.

Involvement of ErbB-2 in rheumatoid synovial cell growth.

Satoh K, Kikuchi S, Sekimata M, Kabuyama Y, Homma MK, Homma Y.

Arthritis Rheum. 2001 Feb;44(2):260-5.

18.

Cutting edge: essential role of phospholipase C-gamma 2 in B cell development and function.

Hashimoto A, Takeda K, Inaba M, Sekimata M, Kaisho T, Ikehara S, Homma Y, Akira S, Kurosaki T.

J Immunol. 2000 Aug 15;165(4):1738-42.

19.

Morphological changes and detachment of adherent cells induced by p122, a GTPase-activating protein for Rho.

Sekimata M, Kabuyama Y, Emori Y, Homma Y.

J Biol Chem. 1999 Jun 18;274(25):17757-62.

20.
21.

Visualization of protein kinase activities in single cells by antibodies against phosphorylated vimentin and GFAP.

Inagaki N, Tsujimura K, Tanaka J, Sekimata M, Kamei Y, Inagaki M.

Neurochem Res. 1996 Jul;21(7):795-800. Review.

PMID:
8992382
22.

Primary structure of light and heavy chain variable regions of antibodies recognizing phosphorylated vimentins.

Tsujino S, Sekimata M, Inagaki N, Kamie Y, Higashihara M, Kurokawa K, Imajoh-Ohmi S, Inagaki M.

Biochem Biophys Res Commun. 1996 Feb 15;219(2):633-7.

PMID:
8605039
23.

Detection of protein kinase activity specifically activated at metaphase-anaphase transition.

Sekimata M, Tsujimura K, Tanaka J, Takeuchi Y, Inagaki N, Inagaki M.

J Cell Biol. 1996 Feb;132(4):635-41.

24.

Differential targeting of protein kinase C and CaM kinase II signalings to vimentin.

Ogawara M, Inagaki N, Tsujimura K, Takai Y, Sekimata M, Ha MH, Imajoh-Ohmi S, Hirai S, Ohno S, Sugiura H, et al.

J Cell Biol. 1995 Nov;131(4):1055-66.

25.
26.

Different effects of substitutions at residues 224 and 228 of MHC class I on the recognition of CD8.

Sekimata M, Tanabe M, Sarai A, Yamamoto J, Kariyone A, Nakauchi H, Egawa K, Takiguchi M.

J Immunol. 1993 May 15;150(10):4416-26.

PMID:
8482843
27.

Isolation of human minor histocompatibility peptides from cultured kidney cells.

Beck Y, Sekimata M, Nakayama S, Müller GA, Müller CA, Yamamoto J, Nagao T, Uchida H, Akiyama N, Kariyone A, et al.

Transplant Proc. 1993 Feb;25(1 Pt 1):162-6. No abstract available.

PMID:
8382382
28.

Expression of human minor histocompatibility antigen on cultured kidney cells.

Beck Y, Sekimata M, Nakayama S, Müller GA, Müller CA, Yamamoto J, Nagao T, Uchida H, Akiyama N, Kariyone A, et al.

Eur J Immunol. 1993 Feb;23(2):467-72.

PMID:
8382163
29.
30.

Isolation of human minor histocompatibility peptides.

Sekimata M, Griem P, Egawa K, Rammensee HG, Takiguchi M.

Int Immunol. 1992 Feb;4(2):301-4.

PMID:
1622900
31.

Detection of allogeneic Qa/TL and Ly specificities on murine tumor cells with IgD in tumor-regressor serum.

Tanino T, Seo N, Okazaki T, Nakanishi-Ito C, Sekimata M, Egawa K.

Cancer Immunol Immunother. 1992;35(4):230-6.

PMID:
1380893
32.

Allodeterminants and evolution of a novel HLA-B5 CREG antigen, HLA-B SNA.

Sekimata M, Hiraiwa M, Andrien M, Dupont E, Karaki S, Yamamoto J, Kano K, Takiguchi M.

J Immunol. 1990 Apr 15;144(8):3228-33.

PMID:
1691230
33.

Allospecificities between HLA-Bw53 and HLA-B35 are generated by substitution of the residues associated with HLA-Bw4/Bw6 public epitopes.

Hayashi H, Ooba T, Nakayama S, Sekimata M, Kano K, Takiguchi M.

Immunogenetics. 1990;32(3):195-9. No abstract available.

PMID:
1699887
34.

A beta-Galactosidase from Radish (Raphanus sativus L.) Seeds.

Sekimata M, Ogura K, Tsumuraya Y, Hashimoto Y, Yamamoto S.

Plant Physiol. 1989 Jun;90(2):567-74.

35.

Serological demonstration of HLA-Bw4/Bw6 epitopes on hybrid molecules between HLA-B35 and HLA-B51.

Sekimata M, Hayashi H, Nakayama S, Kano K, Takiguchi M.

Immunogenetics. 1989;30(3):229-31. No abstract available.

PMID:
2476390

Supplemental Content

Loading ...
Support Center